- Home
- CIM vs BLFS Comparison
CIM vs BLFS Comparison
Compare CIM & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIM
- BLFS
- Stock Information
- Founded
- CIM 2007
- BLFS 1987
- Country
- CIM United States
- BLFS United States
- Employees
- CIM N/A
- BLFS N/A
- Industry
- CIM Real Estate Investment Trusts
- BLFS Medical/Dental Instruments
- Sector
- CIM Real Estate
- BLFS Health Care
- Exchange
- CIM Nasdaq
- BLFS Nasdaq
- Market Cap
- CIM 1.1B
- BLFS 1.2B
- IPO Year
- CIM 2007
- BLFS 1989
- Fundamental
- Price
- CIM $14.14
- BLFS $25.91
- Analyst Decision
- CIM Buy
- BLFS Strong Buy
- Analyst Count
- CIM 3
- BLFS 7
- Target Price
- CIM $15.50
- BLFS $30.86
- AVG Volume (30 Days)
- CIM 509.5K
- BLFS 563.0K
- Earning Date
- CIM 08-06-2025
- BLFS 08-07-2025
- Dividend Yield
- CIM 10.47%
- BLFS N/A
- EPS Growth
- CIM N/A
- BLFS N/A
- EPS
- CIM 1.28
- BLFS N/A
- Revenue
- CIM $312,281,000.00
- BLFS $93,468,000.00
- Revenue This Year
- CIM $18.51
- BLFS $21.22
- Revenue Next Year
- CIM $3.88
- BLFS $17.50
- P/E Ratio
- CIM $11.01
- BLFS N/A
- Revenue Growth
- CIM 1.91
- BLFS 68.16
- 52 Week Low
- CIM $9.85
- BLFS $19.10
- 52 Week High
- CIM $16.89
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- CIM 58.86
- BLFS 67.88
- Support Level
- CIM $13.53
- BLFS $24.10
- Resistance Level
- CIM $13.93
- BLFS $25.78
- Average True Range (ATR)
- CIM 0.28
- BLFS 1.25
- MACD
- CIM 0.05
- BLFS 0.30
- Stochastic Oscillator
- CIM 96.45
- BLFS 93.73
About CIM Chimera Investment Corporation
Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.